Roche’s Analyst Event from SABCS 2019

Agenda:

Welcome

HER2+ Franchise Overview

HR+ and TNBC Franchise Overview

Key Early Stage Data Presented at SABCS (GDC-0077 and GDC-9545)

Q&A

Karl Mahler, Head of Investor Relations

Alan Sandler, Sr. Vice President, Global Head of Oncology Product Development - Solid Tumors

Elena Bernedo Arzac, Sr. Vice President, Head of Oncology Global Product Strategy

Stuart Lutzker, Vice President BioOncology, gRED Early Clinical Development

Please register to access the replay*

First Name

Last name

Corporate Email

Company Name

Confirm you are a human *

Roche has hosted a live audio webcast on Monday, 16 December 2019

Investors

Downloads

PDF